R&D for cellomics, genomics, and neurocognition

Life & Brain specializes in advanced technologies for omics analyses, particularly focusing on iPSC (induced pluripotent stem cell) based assays and disease modeling. The company offers a comprehensive suite of services that includes the generation of various neuronal cell types, such as microglia and excitatory neurons, as well as customized assay development for neurological and neuropsychiatric diseases. Their expertise extends to molecular karyotyping, nucleic acid extraction, and next-generation sequencing, which are essential for understanding complex biological systems and developing targeted therapies. Life & Brain's commitment to quality is reflected in their robust differentiation protocols and the establishment of quality control measures for their iPSC-derived products.

In addition to their cell-based technologies, Life & Brain is actively involved in research and development, collaborating with academic institutions and participating in international consortia to stay at the forefront of scientific advancements. Their focus on genomics includes the development of innovative methods for generating and interpreting omics data, which supports the establishment of new diagnostic and therapeutic procedures. The company also emphasizes the integration of AI-based phenotyping and multidimensional imaging in their drug discovery processes, enhancing the efficiency and accuracy of compound validation. Through these initiatives, Life & Brain aims to bridge the gap between cutting-edge research and practical applications in the field of neuroscience.

Germany

Your partner for nucleic acid extraction, biobanking, genotyping, epigenetics, transcriptomics, NGS, proteomics and bioinformatics. 

Life & Brain

Company Details